e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported) April 21, 2009
E. I. du Pont de Nemours and Company
(Exact Name of Registrant as Specified in Its Charter)
         
Delaware
(State or Other Jurisdiction
Of Incorporation)
  1-815
(Commission
File Number)
  51-0014090
(I.R.S. Employer
Identification No.)
1007 Market Street
Wilmington, Delaware 19898
(Address of principal executive offices)
Registrant’s telephone number, including area code: (302) 774-1000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Section 2 — Financial Information
Item 2.02 Results of Operations and Financial Condition
     On April 21, 2009, the Registrant announced its consolidated financial results for the quarter ended March 31, 2009. A copy of the Registrant’s earnings news release is furnished on Form 8-K. The information contained in Item 2.02 of this report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed by the Registrant under the Securities Act of 1933, as amended, or the Exchange Act.

2


 

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  E. I. DU PONT DE NEMOURS AND COMPANY
(Registrant)
 
 
  /s/ Barry J. Niziolek    
  Barry J. Niziolek   
  Vice President and Controller   
 
April 21, 2009

3


 

         
APRIL 21, 2009
WILMINGTON, Del.
  Media Contact:   Anthony Farina
302-773-4418
anthony.r.farina@usa.dupont.com
 
       
 
  Investor Contact:   302-774-4994
DuPont Reports First Quarter 2009 Earnings In-Line with Guidance
Company Expands Actions to Further Strengthen Competitiveness, Address Weak Global Outlook
Highlights:
    DuPont’s first quarter 2009 earnings were $.54 per share, in-line with guidance. Results reflect earnings from Agriculture & Nutrition and pharmaceuticals, strong companywide pricing and cost discipline, partly offset by the impact of a severe decline in global industrial demand.
 
    The Agriculture & Nutrition segment performance was strong, with sales growth of 6 percent and earnings growth of 8 percent despite significant currency headwinds. Performance was driven by higher North American volumes and significant seed pricing gains.
 
    DuPont increased its 2009 fixed cost reduction goal to $1 billion and reduced planned capital expenditures an additional $200 million, to $1.4 billion.
 
    The company revised its full-year 2009 earnings outlook to a range of $1.70 to $2.10 per share, with the expectation of difficult market conditions continuing with the exception of global agriculture markets.
 
    DuPont declared a second quarter dividend of $.41 per share, unchanged from the first quarter. This is the company’s 419th consecutive dividend.
          “Our strong first quarter performance in Agriculture & Nutrition and pharmaceuticals, combined with gains from our pricing discipline and cost and capital reductions, helped to offset the impact of the largest decline in industrial demand in decades,” said DuPont CEO Ellen J. Kullman. “As we committed to do in December, we are addressing the more challenging economic conditions with further steps to aggressively manage costs, enhance productivity and operate even more efficiently.”
          “Our teams are working with urgency and agility to stay ahead of the worst global recession since the 1930s,” Kullman said. “Our preemptive actions will preserve our strong cash generating capability, while positioning our businesses for improved profitability as global markets rebound.”

 


 

2

Net Income and Global Consolidated Sales
          Net income attributable to DuPont for the first quarter 2009 was $488 million versus $1,191 million in the prior year. Consolidated net sales in the first quarter of $6.9 billion were 20 percent lower than prior year, reflecting 19 percent lower volume and a net 1 percent reduction due to portfolio changes. Five percent higher local prices were offset by a 5 percent negative impact from currency. Lower sales volume principally reflects global declines in construction, motor vehicle production and consumer spending, which was magnified by inventory de-stocking across most supply chains. The table below shows worldwide and regional sales performance for first quarter 2009 versus first quarter 2008.
                                                 
    Three Months Ended    
    March 31, 2009   Percentage Change Due to:
                    Local                
            %   Currency   Currency           Portfolio/
(dollars in billions)   $   Change   Price   Effect   Volume   Other
U.S.
  $ 3.1       (9 )     6             (14 )     (1 )
Europe
    2.1       (28 )     3       (11 )     (20 )      
Asia Pacific
    0.9       (28 )     5       (1 )     (31 )     (1 )
Canada & Lat. America
    0.8       (22 )     9       (11 )     (19 )     (1 )
 
Total Consolidated Sales
  $ 6.9       (20 )     5       (5 )     (19 )     (1 )
Earnings Per Share
          The table below shows the variances in first quarter 2009 earnings per share (EPS) versus first quarter 2008.
EPS ANALYSIS
         
    1Q  
 
EPS — 2008
  $ 1.31  
 
     
 
Local prices
    .37  
Variable costs*
    (.16 )
Volume
    (.62 )
Low Capacity Utilization**
    (.18 )
Fixed costs *
    .05  
Currency
    (.18 )
Exchange loss
    (.02 )
Tax
    .02  
Other***
    (.05 )
 
     
 
EPS — 2009
  $ .54  
 
     
 
*   Excluding volume & currency impact.
 
**   Fixed manufacturing cost, normally reflected in inventory, expensed as a result of low production volumes.
 
***   Includes interest expense, income from pharmaceuticals and equity affiliates, and the impact of portfolio changes.


 

3

Business Segment Performance
          The tables below show first quarter 2009 segment sales and related variances versus prior year, and pre-tax operating income (loss). Segment operating performance reflects pre-tax operating income (PTOI) improvements versus prior year for Agriculture & Nutrition and pharmaceuticals which were more than offset by substantial earnings declines for the other four segments. The earnings decline for those segments, principally reflecting a combined 30 percent drop in sales volume versus prior year, was partly offset by about $250 million in companywide fixed cost reduction programs.
                                         
    Three Months Ended
March 31, 2009
  Percentage Change
Due to:
SEGMENT SALES*     USD     Portfolio
(Dollars in billions)   $   % Change   Price   Volume   and Other
Agriculture & Nutrition
  $ 3.1       6       5       1        
Coatings & Color Technologies
    1.2       (30 )     (1 )     (29 )      
Electronic & Communication Technologies
    0.7       (32 )     (1 )     (31 )      
Performance Materials
    0.9       (45 )     (3 )     (39 )     (3 )
Safety & Protection
    1.0       (24 )     (5 )     (18 )     (1 )
 
  Segment sales include transfers
PRE-TAX OPERATING INCOME (LOSS)
                 
    Three Months Ended  
    Mar 31, 2009  
(Dollars in millions)   2009     2008  
 
               
Agriculture & Nutrition
  $ 852     $ 786  
Coatings & Color Technologies
    (19 )     190  
Electronic & Communication Technologies
    (54 )     175  
Performance Materials
    (146 )     219  
Safety & Protection
    72       272  
 
           
Total Growth Platforms
    705       1,642  
Pharmaceuticals
    252       235  
Other
    (44 )     (26 )
 
           
Total Segments
  $ 913     $ 1,851  


 

4

The following is a summary of business results for each of the company’s operating segments, comparing sales and PTOI (loss) for first quarter 2009 versus first quarter 2008. All references to selling price changes are on a U.S. dollar basis, including the impact of currency.
Agriculture & Nutrition
  Sales of $3.1 billion were up 6 percent reflecting production agriculture price increases and North America and Europe seed volume gains, partly offset by currency.
  PTOI was $852 million, up 8 percent, driven by higher sales, partly offset by significant unfavorable currency impact and increased input costs.
Coatings & Color Technologies
  Sales of $1.2 billion were down 30 percent primarily reflecting broad-based volume declines across all regions and businesses.
  The pre-tax loss of $19 million reflects lower sales volumes and unfavorable currency impact partly offset by fixed cost reductions and higher local prices.
Electronic & Communication Technologies
  Sales of $696 million were down 32 percent reflecting 31 percent lower volumes and 1 percent lower selling prices. Lower volumes reflect significant de-stocking in supply chains for many electronic materials and general industrial markets.
  The pre-tax loss of $54 million reflects the depressed sales volumes and higher input costs, partly offset by fixed cost reductions.
Performance Materials
  Sales of $942 million were down 45 percent reflecting declines in major markets in all regions, precipitated by de-stocking and weak final demand, particularly in motor vehicle and general industrial end markets.
  The pre-tax loss of $146 million reflects lower volume and higher raw material costs, partly offset by reductions in fixed costs.
Safety & Protection
  Sales of $1.0 billion were down 24 percent reflecting an 18 percent volume decline and 5 percent lower selling prices. Volumes were down in all product lines, most significantly in North American and European motor vehicle, construction and general industrial markets.
  PTOI of $72 million principally reflects the impact of lower sales volumes.
Additional information on segment performance is available on the DuPont Investor Center website at www.dupont.com.


 

5

2009 Cost Reduction and Productivity Actions
          DuPont is expanding actions to address weaker global market conditions and further enhance its long-term competitiveness, which include higher 2009 targets for cost and capital reductions. Below is a summary of the company’s additional actions:
  The company is increasing its 2009 fixed cost reduction goal from $730 million to $1 billion. In December 2008, DuPont initiated $600 million in fixed cost reduction projects and a restructuring program with $130 million in restructuring benefits for 2009. The company has now identified an additional $200 million in cost reduction actions, including reducing additional contractor positions and work schedule reductions. DuPont is also developing plans for additional restructuring actions, expected to be finalized and approved in the second quarter 2009, with a targeted $70 million pre-tax savings and positive cash flow benefit in 2009. This is in addition to restructuring plans announced in December 2008.
 
  The company is reducing 2009 capital expenditures from $1.6 billion to $1.4 billion, 30 percent below 2008 expenditures of $2.0 billion.
 
  Working capital reduction projects are fully underway and expected to deliver a $1 billion improvement over 2008, as previously announced.
 
  Based on the above, the full year outlook for free cash flow remains about $2.5 billion.
Outlook
          The company’s 2009 earnings outlook has been revised downward to a range of $1.70 to $2.10 per share, excluding any significant items. The revision anticipates that weak demand across key markets will continue throughout 2009. While favorable conditions in global agriculture markets and the benefit of cost reductions and lower raw material costs are expected, the protracted recessionary environment and the impact of currency are expected to limit the company’s revenue growth. DuPont will continue aggressive actions to reduce costs and capital expenditures, in addition to maintaining an appropriate level of investment for high-growth, high-margin businesses including seed products and photovoltaics.
          For the second quarter 2009, the company anticipates revenue growth to be limited by continuing weak demand in non-agriculture markets, the negative impact of currency, with some sequential improvement due to less de-stocking across multiple value chains. DuPont’s Agriculture & Nutrition segment anticipates modest year-over-year revenue growth driven by pricing and volume gains partly offset by currency. The company will continue its aggressive cost and capital reduction programs.


 

6

Use of Non-GAAP Measures
          Management believes that certain non-GAAP measurements, such as free cash flow, are meaningful to investors because they provide insight with respect to ongoing operating results of the company. Such measurements are not recognized in accordance with generally accepted accounting principles (GAAP) and should not be viewed as an alternative to GAAP measures of performance. Reconciliations of non-GAAP measures to GAAP are provided in schedules C and D.
          DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.
Forward-Looking Statements: This news release contains forward-looking statements based on management’s current expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the company’s strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like “expects,” “anticipates,” “plans,” “intends,” “projects,” “indicates,” and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents filed with the Securities and Exchange Commission by DuPont, particularly its latest annual report on Form 10-K and quarterly report on Form 10-Q, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw materials, research and development of new products, including regulatory approval and market acceptance; seasonality of sales of agricultural products; and severe weather events that cause business interruptions, including plant and power outages, or disruptions in supplier and customer operations. The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.
# # #
4/21/09


 

7

E. I. du Pont de Nemours and Company
Consolidated Income Statements
(Dollars in millions, except per share amounts)
SCHEDULE A
                 
    Three Months Ended  
    March 31,  
    2009     2008  
 
Net sales
  $ 6,871     $ 8,575  
Other income, net
    399       195  
 
           
Total
    7,270       8,770  
 
               
Cost of goods sold and other operating charges
    5,185       5,956  
Selling, general and administrative expenses
    907       934  
Research and development expense
    323       330  
Interest expense
    106       80  
 
           
Total
    6,521       7,300  
 
               
Income before income taxes
    749       1,470  
Provision for income taxes
    260       273  
 
           
Net income
    489       1,197  
 
               
Less: Net income attributable to noncontrolling interests
    1       6  
 
           
Net income attributable to DuPont
  $ 488     $ 1,191  
 
           
Basic earnings per share of common stock
  $ 0.54     $ 1.32  
 
           
Diluted earnings per share of common stock
  $ 0.54     $ 1.31  
 
           
Dividends per share of common stock
  $ 0.41     $ 0.41  
 
           
 
               
Average number of shares outstanding used in earnings per share (EPS) calculation:
               
Basic
    903,893,000       900,646,000  
Diluted
    905,665,000       906,193,000  


 

8

E. I. du Pont de Nemours and Company
Consolidated Balance Sheets
(Dollars in millions, except per share amounts)
SCHEDULE A (continued)
                 
    March 31,     December 31,  
    2009     2008  
Assets
               
Current assets
               
Cash and cash equivalents
  $ 2,386     $ 3,645  
Marketable securities
    21       59  
Accounts and notes receivable, net
    6,423       5,140  
Inventories
    4,615       5,681  
Prepaid expenses
    200       143  
Income taxes
    570       643  
 
           
Total current assets
    14,215       15,311  
Property, plant and equipment, net of accumulated depreciation
(March 31, 2009 — $17,117; December 31, 2008 — $16,800)
    11,164       11,154  
Goodwill
    2,128       2,135  
Other intangible assets
    2,612       2,710  
Investment in affiliates
    877       844  
Other assets
    3,892       4,055  
 
           
 
               
Total
  $ 34,888     $ 36,209  
 
           
 
               
Liabilities and Stockholders’ Equity
               
Current liabilities
               
Accounts payable
  $ 2,300     $ 3,128  
Short-term borrowings and capital lease obligations
    1,569       2,012  
Income taxes
    155       110  
Other accrued liabilities
    3,578       4,460  
 
           
Total current liabilities
    7,602       9,710  
 
               
Long-term borrowings and capital lease obligations
    8,490       7,638  
Other liabilities
    11,011       11,169  
Deferred income taxes
    142       140  
 
           
Total liabilities
    27,245       28,657  
 
           
 
               
Commitments and contingent liabilities
               
 
               
Stockholders’ equity
               
Preferred stock
    237       237  
Common stock, $0.30 par value; 1,800,000,000 shares authorized; issued at March 31, 2009 — 990,624,000; December 31, 2008 — 989,415,000
    297       297  
Additional paid-in capital
    8,396       8,380  
Reinvested earnings
    10,569       10,456  
Accumulated other comprehensive loss
    (5,558 )     (5,518 )
Common stock held in treasury, at cost (87,041,000 shares at March 31, 2009 and December 31, 2008)
    (6,727 )     (6,727 )
 
           
Total DuPont stockholders’ equity
    7,214       7,125  
 
           
Noncontrolling interests
    429       427  
 
           
Total stockholders’ equity
    7,643       7,552  
 
           
 
               
Total
  $ 34,888     $ 36,209  
 
           


 

9

E. I. du Pont de Nemours and Company
Condensed Consolidated Statements of Cash Flows
(Dollars in millions)
SCHEDULE A (continued)
                 
    Three Months Ended  
    March 31,  
    2009     2008  
 
               
Cash used for operating activities
  $ (832 )   $ (951 )
 
           
 
               
Investing activities
               
Purchases of property, plant and equipment
    (358 )     (410 )
Investments in affiliates
    (8 )     (3 )
Other investing activities — net
    (27 )     (107 )
 
           
Cash used for investing activities
    (393 )     (520 )
 
               
Financing activities
               
Dividends paid to stockholders
    (375 )     (372 )
Net increase in borrowings
    433       1,611  
Other financing activities — net
    (38 )     23  
 
           
Cash provided by financing activities
    20       1,262  
 
               
Effect of exchange rate changes on cash
    (54 )     (2 )
 
           
Decrease in cash and cash equivalents
    (1,259 )     (211 )
 
               
Cash and cash equivalents at beginning of period
    3,645       1,305  
 
           
 
               
Cash and cash equivalents at end of period
  $ 2,386     $ 1,094  
 
           


 

10

E. I. du Pont de Nemours and Company
Schedules of Significant Items
(Dollars in millions, except per share amounts)
SCHEDULE B
SIGNIFICANT ITEMS
There were no significant items for the three months ended March 31, 2009 and 2008, respectively.


 

11

E. I. du Pont de Nemours and Company
Consolidated Segment Information
(Dollars in millions)
SCHEDULE C
                 
    Three Months Ended  
    March 31,  
SEGMENT SALES (1)   2009     2008  
Agriculture & Nutrition
  $ 3,062     $ 2,883  
Coatings & Color Technologies
    1,156       1,645  
Electronic & Communication Technologies
    696       1,026  
Performance Materials
    942       1,713  
Safety & Protection
    1,033       1,365  
Other
    28       40  
 
           
Total Segment sales
  $ 6,917     $ 8,672  
 
               
Elimination of transfers
    (46 )     (97 )
 
           
Consolidated net sales
  $ 6,871     $ 8,575  
 
           
                 
    Three Months Ended  
    March 31,  
PRETAX OPERATING INCOME/(LOSS) (PTOI)   2009     2008  
Agriculture & Nutrition
  $ 852     $ 786  
Coatings & Color Technologies
    (19 )     190  
Electronic & Communication Technologies
    (54 )     175  
Performance Materials
    (146 )     219  
Safety & Protection
    72       272  
 
           
Total Growth Platforms
    705       1,642  
 
               
Pharmaceuticals
    252       235  
Other
    (44 )     (26 )
 
           
Total Segment PTOI
  $ 913     $ 1,851  
 
               
Net exchange gains (losses) (2)
    70       (155 )
Corporate expenses & net interest
    (234 )     (226 )
 
           
Income before income taxes
  $ 749     $ 1,470  
 
           
 
(1)   Sales for the reporting segments include transfers.
 
(2)   Net after-tax exchange activity for the three months ended March 31, 2009 and 2008 were losses of $33 and $14, respectively. Gains and losses resulting from the company’s hedging program are largely offset by associated tax effects. See Schedule D for additional information.


 

12

E. I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
SCHEDULE D
Reconciliations of EBIT / EBITDA to Consolidated Income Statement
                 
    Three Months Ended  
    March 31,  
    2009     2008  
 
               
Income before income taxes
  $ 749     $ 1,470  
Less: Net income attributable to noncontrolling interests
    1       6  
Add: Interest expense
    106       80  
 
           
Adjusted EBIT
    854       1,544  
Add: Depreciation and amortization
    399       380  
 
           
Adjusted EBITDA
  $ 1,253     $ 1,924  
 
           
Reconciliations of Fixed Costs as a Percent of Sales
                 
    Three Months Ended  
    March 31,  
    2009     2008  
 
               
Total charges and expenses — consolidated income statements
  $ 6,521     $ 7,300  
Remove:
               
Interest expense
    (106 )     (80 )
Variable costs (1)
    (3,434 )     (4,140 )
 
           
Fixed costs
  $ 2,981     $ 3,080  
 
           
 
               
Consolidated net sales
  $ 6,871     $ 8,575  
 
               
Fixed costs as a percent of consolidated net sales
    43.4 %     35.9 %
 
(1)   Includes variable manufacturing costs, freight, commissions and other selling expenses which vary with the volume of sales.
Calculation of Free Cash Flow
                 
    Three Months Ended  
    March 31,  
    2009     2008  
Cash used by operating activities
  $ (832 )   $ (951 )
Less: Purchases of property, plant and equipment
    358       410  
 
           
Free cash flow
  $ (1,190 )   $ (1,361 )
 
           


 

13

E. I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
SCHEDULE D (continued)
Exchange Gains/Losses
The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes. The net pretax exchange gains and losses are recorded in Other income, net on the Consolidated Income Statements and are largely offset by the associated tax impact.
                 
    Three Months Ended
March 31,
 
    2009     2008  
Subsidiary/Affiliate Monetary Position Gain/(Loss)
               
Pretax exchange gains (losses) (includes equity affiliates)
  $ (125 )   $ 150  
Local tax benefits (expenses)
    (32 )     34  
 
           
Net after-tax impact from subsidiary exchange gains (losses)
  $ (157 )   $ 184  
 
           
 
               
Hedging Program Gain/(Loss)
               
Pretax exchange gains (losses)
  $ 195     $ (305 )
Tax benefits (expenses)
    (71 )     107  
 
           
Net after-tax impact from hedging program exchange gains (losses)
  $ 124     $ (198 )
 
           
 
               
Total Exchange Gain/(Loss)
               
Pretax exchange gains (losses)
  $ 70     $ (155 )
Tax benefits (expenses)
    (103 )     141  
 
           
Net after-tax exchange losses
  $ (33 )   $ (14 )
 
           
As shown above, the “Total Exchange Gain (Loss)” is the sum of the “Subsidiary/Affiliate Monetary Position Gain (Loss)” and the “Hedging Program Gain (Loss).”
Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
Base income tax rate is defined as the effective income tax rate less the effect of exchange gains/losses, as defined above.
                 
    Three Months Ended
March 31,
 
    2009     2008  
Income before income taxes
  $ 749     $ 1,470  
Less: Net exchange gains (losses)
    70       (155 )
 
           
Income before income taxes and exchange gains/losses
  $ 679     $ 1,625  
 
           
 
               
Provision for income taxes
  $ 260     $ 273  
Tax benefits (expenses) on exchange gains/losses
    (103 )     141  
 
           
Provision for income taxes, excluding taxes on exchange gains/losses
  $ 157     $ 414  
 
           
 
               
Effective income tax rate
    34.7 %     18.6 %
Exchange gains/losses effect
    -11.6 %     6.9 %
 
           
Base income tax rate
    23.1 %     25.5 %
 
           


 

14

E. I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
SCHEDULE D (continued)
Reconciliation of Earnings Per Share (EPS) Outlook
                 
    Year Ended  
    December 31,  
    2009     2008  
    Outlook     Actual  
 
Earnings per share — excluding significant items
  $ 1.70 to $2.10     $ 2.78  
Significant items included in EPS:
               
Hurricane charge
          (0.16 )
Restructuring charge
          (0.42 )
 
           
Net charge for significant items
          (0.58 )
 
           
Reported EPS
  $ 1.70 to $2.10     $ 2.20